Nocturnal hypoglycaemia: effect of insulin analogues compared to human insulin in type 1 diabetic patients prone to severe hypoglycaemia

被引:0
|
作者
Bay, C. [1 ,2 ]
Kristensen, P. Lommer [1 ,3 ]
Pedersen-Bjergaard, U. [1 ]
Tarnow, L. [4 ,5 ]
Thorsteinsson, B. [1 ,2 ]
机构
[1] Cent Hosp Hillerod, Dept Cardiol Nephrol & Endocrinol, Endocrinol Sect, Hillerod, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Herlev, Denmark
[3] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark
[4] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[5] Univ Aarhus, DK-8000 Aarhus C, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
584
引用
收藏
页码:S239 / S239
页数:1
相关论文
共 50 条
  • [21] The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
    Rikke Mette Agesen
    Amra Ciric Alibegovic
    Henrik Ullits Andersen
    Henning Beck-Nielsen
    Peter Gustenhoff
    Troels Krarup Hansen
    Christoffer Hedetoft
    Tonny Jensen
    Claus Bogh Juhl
    Susanne Søgaard Lerche
    Kirsten Nørgaard
    Hans-Henrik Parving
    Lise Tarnow
    Birger Thorsteinsson
    Ulrik Pedersen-Bjergaard
    BMC Endocrine Disorders, 19
  • [22] Hypoglycaemia induced by exogenous insulin - 'human' and animal insulin compared
    Airey, CM
    Williams, DRR
    Martin, PG
    Bennett, CMT
    Spoor, PA
    DIABETIC MEDICINE, 2000, 17 (06) : 416 - 432
  • [23] The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials
    K. Dżygało
    D. Golicki
    A. Kowalska
    A. Szypowska
    Acta Diabetologica, 2015, 52 : 231 - 238
  • [24] The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials
    Zygalo, K. D.
    Golicki, D.
    Kowalska, A.
    Szypowska, A.
    ACTA DIABETOLOGICA, 2015, 52 (02) : 231 - 238
  • [25] Cost-Effectiveness of Insulin Detemir and Insulin Aspart in People with Type 1 Diabetes Prone to Recurrent Severe Hypoglycaemia
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Norgaard, Kirsten
    Perrild, Hans
    Jensen, Tonny
    Thorsteinsson, Birger
    Nikolajsen, Annie
    Tarnow, Lise
    DIABETES, 2015, 64 : A348 - A348
  • [26] Metabolic control and hypoglycaemia in 5,891 type 1 diabetic patients on human insulin (HI) or insulin analogues (AI) in routine care in Germany 2005
    Mueller, U. A.
    Mueller, N.
    Kerner, W.
    Hauner, H.
    Osterbrink, B.
    Schiel, R.
    Beyer, P.
    DIABETOLOGIA, 2006, 49 : 594 - 595
  • [27] Ultra-long-acting insulin degludec shown to reduce the risk of nocturnal hypoglycaemia compared to insulin glargine in patients with type 1 and type 2 diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2012, 14 (07): : 673 - 673
  • [28] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
    Fritsche, A
    Schweitzer, MA
    Häring, H
    DIABETOLOGIA, 2002, 45 : A52 - A52
  • [29] A bedtime carbohydrate snack for the prevention of nocturnal hypoglycaemia in Type 1-diabetic patients treated with once daily insulin glargine
    Lueg, A
    Schnar, S
    Willms, B
    Nauck, MA
    DIABETOLOGIA, 2001, 44 : A208 - A208
  • [30] Insulin glulisine provides superior postprandial glucose control with less nocturnal hypoglycaemia compared with regular human insulin in subjects with type 2 diabetes
    Rayman, G
    Souhami, E
    DIABETOLOGIA, 2005, 48 : A4 - A4